WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006089150) ANTIANGIOGENIC AGENTS WITH ALDESLEUKIN
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/089150    International Application No.:    PCT/US2006/005720
Publication Date: 24.08.2006 International Filing Date: 17.02.2006
IPC:
A61K 38/20 (2006.01), A61K 31/502 (2006.01), A61K 31/517 (2006.01), A61K 31/404 (2006.01), A61K 31/4412 (2006.01), A61P 35/00 (2006.01)
Applicants: NOVARTIS VACCINES AND DIAGNOSTICS INC. [US/US]; Intellectual Property - R440, P.O. Box 8097, Emeryville, CA 94662-8097 (US) (For All Designated States Except US).
AUKERMAN, Sharon Lea [US/US]; (US) (For US Only).
DENIS-MIZE, Kimberly [US/US]; (US) (For US Only).
ELIAS, Laurence [US/US]; (US) (For US Only).
JALLAL, Bahija [US/US]; (US) (For US Only).
MENEZES, Daniel [PT/US]; (US) (For US Only).
WITHERELL, Gary W. [US/US]; (US) (For US Only)
Inventors: AUKERMAN, Sharon Lea; (US).
DENIS-MIZE, Kimberly; (US).
ELIAS, Laurence; (US).
JALLAL, Bahija; (US).
MENEZES, Daniel; (US).
WITHERELL, Gary W.; (US)
Agent: HARBIN, Alisa, A.; Novartis Vaccines and Diagnostics Inc., P.O. Box 8097, Emeryville, CA 94662-8097 (US)
Priority Data:
60/654,341 18.02.2005 US
Title (EN) ANTIANGIOGENIC AGENTS WITH ALDESLEUKIN
(FR) AGENTS ANTI-ANGIOGENIQUES COMPORTANT DE L'ALDESLEUKINE
Abstract: front page image
(EN)The present invention relates to combination therapies with IL-2 compositions and antiangiogenic agents for the treatment of cancer. Further provided are methods of alleviating toxicities and increasing the efficacy associated with the administration of IL-2 compositions or antiangiogenic compositions.
(FR)L'invention concerne une polythérapie faisant appel à des compositions IL-2 et à des agents anti-angiogéniques pour traiter le cancer. En outre, l'invention concerne des méthodes de réduction de toxicités et d'augmentation d'efficacité associées à l'administration de compositions de IL-2 ou de compositions anti-angiogéniques.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)